Security key
462260100
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA)
CUSIP: 462260100
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 154,414,415
- Total 13F value
- $1,478,691,442
- Share change
- -5,001,017
- Put/Call ratio
- 18%
- SEC-reported price per share
- $9.58
- Number of holders
- 231
- Value change
- -$53,630,372
- Number of buys
- 107
- Number of sells
- 108
- Shares outstanding
- 451,979,229
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
231
Top holders
10
IOVA full security history
Ownership snapshot
Full 13F holder table
IOVANCE BIOTHERAPEUTICS, INC. SEC filings
IOVANCE BIOTHERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F
Highest disclosed value: $147,529,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $147.53M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$147.53M
PERCEPTIVE ADVISORS LLC
$130.56M
STATE STREET CORP
$129.95M
BlackRock Finance, Inc.
$127.74M
Avoro Capital Advisors LLC
$101.79M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$147,529,000
13,363,027 shares
|
— | 30 Jun 2022 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$130,562,000
11,826,299 shares
|
— | 30 Jun 2022 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$129,949,000
11,770,751 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$127,744,000
11,571,066 shares
|
— | 30 Jun 2022 |
| Avoro Capital Advisors LLC |
13F
Company
|
—
denominator unverified
|
$101,789,000
9,220,000 shares
|
— | 30 Jun 2022 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$57,049,000
5,167,507 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
231
Shares
154,414,415
Rows available
231
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
227
Q3 2022 holders
231
Holder diff
4
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|